ClinicalTrials.Veeva

Menu

Safety of Capsule Endoscopy in Patients With Implantable Cardiac Devices

Yonsei University logo

Yonsei University

Status

Completed

Conditions

Anemia
Gastrointestinal Disease

Study type

Observational

Funder types

Other

Identifiers

NCT01360502
1-2009-0021

Details and patient eligibility

About

This is a prospective study designed to assess safety and potential influence of the MiroCam on cardiac pacemaker and implantable cardiac defibrillator.

Full description

MiroCam (IntroMedic, Ltd, Seoul, Korea) is a small bowel capsule endoscope using human body communication for data transmission. There is a concern of potential interactions between cardiac devices and capsule endoscope. This clinical study was designed to evaluate the potential influence of the MiroCam on cardiac pacemaker and implantable cardiac defibrillator.

Enrollment

6 patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. age 20 years or older
  2. cardiac pacemaker or implantable cardiac defibrillator
  3. gastrointestinal disease

Exclusion criteria

  1. previous GI perforation or obstruction history
  2. known or suspected GI stricture
  3. marked GI dysmotility
  4. uncompensated heart failure (EF ≤30% or Killip's classification class ≥ III)
  5. pregnancy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems